e-learning
resources
London 2016
Tuesday, 06.09.2016
What can respiratory medicine learn from cystic fibrosis research?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The central role of CFTR in lung disease
Stuart Elborn (Belfast, United Kingdom)
Source:
International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?
Session:
What can respiratory medicine learn from cystic fibrosis research?
Session type:
Hot topics
Number:
3298
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Stuart Elborn (Belfast, United Kingdom). The central role of CFTR in lung disease. International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
The emerging role of transient receptor potential channels in chronic lung disease
Source: Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016
Year: 2017
A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease?
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
The pathomechanistic role of autophagy in lung fibrosis
Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways
Year: 2017
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: ERS Lung Science Conference 2017
Year: 2017
Low telomerase expression in alveolar epithelial plays a role in the pathogenesis of idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
The lung epithelial clock and its role in lung inflammation
Source: International Congress 2017 – The circadian molecular clock in respiratory diseases and associated interventions
Year: 2017
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020
The role of macrophages in interstitial lung diseases
Source: Eur Respir Rev, 26 (145) 170009; 10.1183/16000617.0009-2017
Year: 2017
The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
Role of the CFTR gene in determining chronic pulmonary diseases in the paediatric population
Source: Eur Respir J 2001; 18: Suppl. 33, 155s
Year: 2001
The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
The role of regulator and effector T lymphocytes in chronic obstructive pulmonary disease and lung cancer
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010
Extracellular vesicles and their role in lung homeostasis and disease
Source: International Congress 2018 – Cross-talk in the lung microenvironment: implications for chronic lung disease
Year: 2018
The role of surfactant on chronic infant lung disease
Source: Annual Congress 2003 - Chronic infant lung disease
Year: 2003
The pIgR-IgA system as a new player in lung fibrosis
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021
Role of the inflammasome in the pathophysiology of antisynthetase-associated interstitial lung disease.
Source: Virtual Congress 2021 – Clinical evolution, management and outcomes of patients with rare diffuse parenchymal lung diseases
Year: 2021
The role of viruses in the pathogenesis of pulmonary fibrosis
Source: Virtual Congress 2021 – Viral infections trigger chronic lung damage and disease
Year: 2021
Increased endothelial and epithelial apoptosis play a central role in the pathogenesis of systemic sclerosis and idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008
A crucial role for lung interstitial macrophages in preventing airway allergy
Source: Annual Congress 2009 - Infections, immunity and inflammation
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept